- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03162146
Team Elements Associated With Mortality in Intensive Care (TEAMIC)
May 19, 2017 updated by: Hospices Civils de Lyon
Influence of Medical and Nursing Teams Composition on Patient Mortality in Intensive Care
The individual characteristics and interactions of health care workers in intensive care units may influence patient safety.
This study aims to quantify the influence of team familiarity among the members of medical and nursing staffs on risk of patient death.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
43378
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lyon, France, 69317
- Service de Réanimation médicale, Hôpital de la Croix Rousse
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patient admitted to intensive care unit
Description
Inclusion Criteria:
- All patients who were admitted to 9 French intensive care units from January 1st 2011 to December 31st 2016
Exclusion Criteria:
- Patients admitted in pediatrics intensive care units and in specialized burns units
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patient admitted to intensive care unit
All patients requiring intensive care unit stay
|
Assessment of the influence of team familiarity among the members of medical and nursing staffs on risk of patient death
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient mortality
Time Frame: At the time of intensive care unit discharge up to a maximum of 6 years since admission
|
Mortality with stratification on patients for whom a forego life-sustaining therapy decision was made
|
At the time of intensive care unit discharge up to a maximum of 6 years since admission
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
July 1, 2017
Primary Completion (Anticipated)
September 1, 2017
Study Completion (Anticipated)
September 1, 2017
Study Registration Dates
First Submitted
May 17, 2017
First Submitted That Met QC Criteria
May 19, 2017
First Posted (Actual)
May 22, 2017
Study Record Updates
Last Update Posted (Actual)
May 22, 2017
Last Update Submitted That Met QC Criteria
May 19, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 69HCL17_0031
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Death
-
Amasya UniversityHealth Institutes of TurkeyCompleted
-
Johns Hopkins Bloomberg School of Public HealthEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedSudden Infant Death SyndromeUnited States
-
Weill Medical College of Cornell UniversityEmpatica, Inc.Terminated
-
Children's Hospital Medical Center, CincinnatiEvery Child Succeeds; de Cavel Family SIDS FoundationCompletedSudden Infant Death Syndrome (SIDS)United States
-
Harvard School of Public Health (HSPH)Population Services International; Community Empowerment LabCompletedPerinatal Death | Stillbirth | Neonatal DeathIndia
-
CHU de ReimsCompletedSudden Death in ChildrenFrance
-
Lehigh Valley HospitalCompletedPrevention of Sudden DeathUnited States
-
Nantes University HospitalTerminatedExtra-hospital Sudden DeathFrance
-
Rachel Moon, MDCompletedSudden Infant Death SyndromeUnited States
-
National Center for Research Resources (NCRR)CompletedSudden Infant Death Syndrome
Clinical Trials on Deaths in intensive care unit
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompleted
-
Centre Hospitalier René DubosCompleted
-
GCS Ramsay Santé pour l'Enseignement et la RechercheEuraxi PharmaRecruiting
-
Taoyuan General HospitalNational Yang Ming University; Ministry of Science and Technology, R.O.C.CompletedQuality of Life | Weaning Failure | ICU Acquired WeaknessTaiwan
-
Saint Savvas Anticancer HospitalUnknownPostoperative Care | Intensive CareGreece
-
Aarhus University HospitalNovo Nordisk A/S; Region MidtJylland Denmark; The Royal Conservatory of MusicNot yet recruiting
-
Norwegian University of Science and TechnologySt. Olavs Hospital; County of South TrøndelagCompletedMental DisordersNorway
-
University Hospital, MontpellierRecruitingNon-ST Elevated Myocardial InfarctionFrance
-
Koç UniversityTerminatedCovid19 | Sarcopenia | Intensive Care Unit Acquired WeaknessTurkey
-
Meir Medical CenterCompleted